Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$47.99 - $60.21 $1.48 Million - $1.86 Million
30,820 New
30,820 $1.56 Million
Q3 2022

Nov 14, 2022

BUY
$57.96 - $78.12 $484,139 - $652,536
8,353 New
8,353 $588,000
Q4 2021

Feb 14, 2022

SELL
$50.01 - $73.35 $342,018 - $501,640
-6,839 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$59.21 - $78.66 $404,937 - $537,955
6,839 New
6,839 $445,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.